{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:12:37Z","timestamp":1791317557762,"version":"4.3.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Capital's Funds for Health Improvement and Research","award":["2020-1-2024"],"award-info":[{"award-number":["2020-1-2024"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970562"],"award-info":[{"award-number":["81970562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Current world experience regarding living donor liver transplantation (LDLT) in the treatment of propionic acidemia (PA) is limited, especially in terms of using obligate heterozygous carriers as donors. This study aimed to evaluate the clinical outcomes of LDLT in children with PA.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From November 2017 to January 2020, 7 of the 192 children who underwent LDLT at our institution had been diagnosed with PA (median age, 2.1\u00a0years; range, 1.1\u20135.8\u00a0years). The primary indication for transplantation was frequent metabolic decompensations in 6 patients and preventative treatment in 1 patient. Of the seven parental living donors, six were genetically proven obligate heterozygous carriers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During a median follow-up of 23.9\u00a0months (range, 13.9\u201340.2\u00a0months), all patients were alive with 100% allograft survival, and no severe transplant-related complications occurred. In the case of liberalized protein intake, they did not suffer metabolic decompensation or disease-related complications and made progress in neurodevelopmental delay and body growth, as well as blood and urinary metabolite levels. In one patient with pre-existing mild dilated cardiomyopathy, her echocardiogram results completely normalized 13.8\u00a0months post-transplant. All living donors recovered well after surgery, with no metabolic decompensations or procedure-related complications. Western blotting revealed that the hepatic expressions of PCCA and PCCB in one of the heterozygous donors were comparable to those of the normal healthy control at the protein level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>LDLT using partial liver grafts from asymptomatic obligate heterozygous carrier donors is a viable therapeutic option for selected PA patients, with no negative impact on donors\u2019 and recipients' clinical courses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02233-9","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:10:51Z","timestamp":1645467051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic potential of living donor liver transplantation from heterozygous carrier donors in children with propionic acidemia"],"prefix":"10.1186","volume":"17","author":[{"given":"Zhi-Gui","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Le","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7031-2083","authenticated-orcid":false,"given":"Zhi-Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"issue":"1","key":"2233_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13023-018-0987-z","volume":"14","author":"T Almasi","year":"2019","unstructured":"Almasi T, Guey LT, Lukacs C, Csetneki K, Voko Z, Zelei T. Systematic literature review and meta-analysis on the epidemiology of propionic acidemia. Orphanet J Rare Dis. 2019;14(1):40.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2233_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ymgme.2017.10.002","volume":"122","author":"P Wongkittichote","year":"2017","unstructured":"Wongkittichote P, Ah Mew N, Chapman KA. Propionyl-CoA carboxylase\u2014a review. Mol Genet Metab. 2017;122(4):145\u201352.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2233_CR3","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","volume":"38","author":"S Kolker","year":"2015","unstructured":"Kolker S, Garcia-Cazorla A, Valayannopoulos V, Lund AM, Burlina AB, Sykut-Cegielska J, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis. 2015;38(6):1041\u201357.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"2233_CR4","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jimd.12129","volume":"42","author":"HA Haijes","year":"2019","unstructured":"Haijes HA, Jans JJM, Tas SY, Verhoeven-Duif NM, van Hasselt PM. Pathophysiology of propionic and methylmalonic acidemias. Part 1: complications. J Inherit Metab Dis. 2019;42(5):730\u201344.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"2233_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ymgme.2019.02.007","volume":"126","author":"E Jurecki","year":"2019","unstructured":"Jurecki E, Ueda K, Frazier D, Rohr F, Thompson A, Hussa C, et al. Nutrition management guideline for propionic acidemia: an evidence- and consensus-based approach. Mol Genet Metab. 2019;126(4):341\u201354.","journal-title":"Mol Genet Metab"},{"key":"2233_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1750-1172-8-6","volume":"8","author":"SC Gr\u00fcnert","year":"2013","unstructured":"Gr\u00fcnert SC, M\u00fcllerleile S, De Silva L, Barth M, Walter M, Walter K, et al. Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients. Orphanet J Rare Dis. 2013;8:6.","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"2233_CR7","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/s41436-019-0593-z","volume":"21","author":"OA Shchelochkov","year":"2019","unstructured":"Shchelochkov OA, Manoli I, Sloan JL, Ferry S, Pass A, Van Ryzin C, et al. Chronic kidney disease in propionic acidemia. Genet Med. 2019;21(12):2830\u20135.","journal-title":"Genet Med"},{"issue":"3","key":"2233_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/jimd.12370","volume":"44","author":"P Forny","year":"2021","unstructured":"Forny P, Horster F, Ballhausen D, Chakrapani A, Chapman KA, Dionisi-Vici C, et al. Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: first revision. J Inherit Metab Dis. 2021;44(3):566\u201392.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2233_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13023-019-1268-1","volume":"14","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Shi Y, Shi Y, Gan LX, Kong YY, Zhu ZJ, et al. Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report. Orphanet J Rare Dis. 2019;14(1):292.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2233_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13023-019-1045-1","volume":"14","author":"TH Chu","year":"2019","unstructured":"Chu TH, Chien YH, Lin HY, Liao HC, Ho HJ, Lai CJ, et al. Methylmalonic acidemia\/propionic academia\u2014the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups. Orphanet J Rare Dis. 2019;14(1):73.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2233_CR11","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1097\/TP.0000000000003501","volume":"105","author":"GP Zhou","year":"2021","unstructured":"Zhou GP, Jiang YZ, Wu SS, Kong YY, Sun LY, Zhu ZJ. Liver transplantation for propionic acidemia: evidence from a systematic review and meta-analysis. Transplantation. 2021;105(10):2272\u201382.","journal-title":"Transplantation"},{"issue":"3","key":"2233_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/jimd.12318","volume":"44","author":"F Molema","year":"2021","unstructured":"Molema F, Martinelli D, H\u00f6rster F, K\u00f6lker S, Tangeraas T, de Koning B, et al. Liver and\/or kidney transplantation in amino and organic acid-related inborn errors of metabolism: an overview on European data. J Inherit Metab Dis. 2021;44(3):593\u2013605.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2233_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/lt.25679","volume":"26","author":"R Curnock","year":"2020","unstructured":"Curnock R, Heaton ND, Vilca-Melendez H, Dhawan A, Hadzic N, Vara R. Liver transplantation in children with propionic acidemia: medium-term outcomes. Liver Transpl. 2020;26(3):419\u201330.","journal-title":"Liver Transpl"},{"issue":"12","key":"2233_CR14","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/lt.25344","volume":"24","author":"J Quintero","year":"2018","unstructured":"Quintero J, Molera C, Juamperez J, Redecillas S, Meavilla S, Nunez R, et al. The role of liver transplantation in propionic acidemia. Liver Transpl. 2018;24(12):1736\u201345.","journal-title":"Liver Transpl"},{"issue":"3","key":"2233_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/ajt.13027","volume":"15","author":"F Charbit-Henrion","year":"2015","unstructured":"Charbit-Henrion F, Lacaille F, McKiernan P, Girard M, de Lonlay P, Valayannopoulos V, et al. Early and late complications after liver transplantation for propionic acidemia in children: a two centers study. Am J Transplant. 2015;15(3):786\u201391.","journal-title":"Am J Transplant"},{"issue":"1","key":"2233_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ymgme.2012.10.022","volume":"108","author":"M Nagao","year":"2013","unstructured":"Nagao M, Tanaka T, Morii M, Wakai S, Horikawa R, Kasahara M. Improved neurologic prognosis for a patient with propionic acidemia who received early living donor liver transplantation. Mol Genet Metab. 2013;108(1):25\u20139.","journal-title":"Mol Genet Metab"},{"key":"2233_CR17","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.ajp.2020.102144","volume":"52","author":"PY Li","year":"2020","unstructured":"Li PY, Fu NN, Li QY, Wang GF, Gao L, Zhang X. The Griffiths Development Scales-Chinese (GDS-C): a reliable and valid neurodevelopmental assessment tool in children with ASD aged 3\u20138 years old in Tianjin, China. Asian J Psychiatr. 2020;52:1144.","journal-title":"Asian J Psychiatr"},{"issue":"11","key":"2233_CR18","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/ejhg.2017.127","volume":"25","author":"M Riemersma","year":"2017","unstructured":"Riemersma M, Hazebroek MR, Helderman-van A, den Enden GS, Salomons SF, Brouwers M, et al. Propionic acidemia as a cause of adult-onset dilated cardiomyopathy. Eur J Hum Genet. 2017;25(11):1195\u2013201.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2233_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jmd2.12090","volume":"51","author":"C Tuchmann-Durand","year":"2020","unstructured":"Tuchmann-Durand C, Thevenet E, Moulin F, Lesage F, Bouchereau J, Oualha M, et al. Administration of gamma-hydroxybutyrate instead of beta-hydroxybutyrate to a liver transplant recipient suffering from propionic acidemia and cardiomyopathy: a case report on a medication prescribing error. JIMD Rep. 2020;51(1):25\u20139.","journal-title":"JIMD Rep"},{"key":"2233_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/8904_2018_137","volume":"45","author":"NP Shanmugam","year":"2019","unstructured":"Shanmugam NP, Valamparampil JJ, Reddy MS, Al Said KJ, Al-Thihli K, Al-Hashmi N, et al. Auxiliary partial orthotopic liver transplantation for monogenic metabolic liver diseases: single-centre experience. JIMD Rep. 2019;45:29\u201336.","journal-title":"JIMD Rep"},{"issue":"1","key":"2233_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jmd2.12053","volume":"48","author":"N Celik","year":"2019","unstructured":"Celik N, Squires JE, Soltys K, Vockley J, Shellmer DA, Chang W, et al. Domino liver transplantation for select metabolic disorders: expanding the living donor pool. JIMD Rep. 2019;48(1):83\u20139.","journal-title":"JIMD Rep"},{"issue":"4","key":"2233_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ymgme.2019.11.001","volume":"128","author":"NR Pillai","year":"2019","unstructured":"Pillai NR, Stroup BM, Poliner A, Rossetti L, Rawls B, Shayota BJ, et al. Liver transplantation in propionic and methylmalonic acidemia: a single center study with literature review. Mol Genet Metab. 2019;128(4):431\u201343.","journal-title":"Mol Genet Metab"},{"issue":"9","key":"2233_CR23","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/lt.25304","volume":"24","author":"K Critelli","year":"2018","unstructured":"Critelli K, McKiernan P, Vockley J, Mazariegos G, Squires RH, Soltys K, et al. Liver transplantation for propionic acidemia and methylmalonic acidemia: perioperative management and clinical outcomes. Liver Transpl. 2018;24(9):1260\u201370.","journal-title":"Liver Transpl"},{"key":"2233_CR24","first-page":"1897495","volume":"2018","author":"M Moguilevitch","year":"2018","unstructured":"Moguilevitch M, Delphin E. Domino liver transplantation from a child with propionic acidemia to a child with idiopathic fulminant hepatic failure. Case Rep Transplant. 2018;2018:1897495.","journal-title":"Case Rep Transplant"},{"issue":"3","key":"2233_CR25","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1097\/MPG.0000000000000626","volume":"64","author":"HM Silva","year":"2017","unstructured":"Silva HM, Nassogne MC, Smets F, Stephenne X, Scheers I, Veyckemans F, et al. Liver transplantation for propionic acidemia. J Pediatr Gastroenterol Nutr. 2017;64(3):e73\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"2233_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/petr.12722","volume":"20","author":"M Honda","year":"2016","unstructured":"Honda M, Sakamoto S, Sakamoto R, Matsumoto S, Irie T, Uchida K, et al. Antibody-mediated rejection after ABO-incompatible pediatric living donor liver transplantation for propionic acidemia: a case report. Pediatr Transplant. 2016;20(6):840\u20135.","journal-title":"Pediatr Transplant"},{"issue":"12","key":"2233_CR27","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/tri.12677","volume":"28","author":"C Arrizza","year":"2015","unstructured":"Arrizza C, De Gottardi A, Foglia E, Baumgartner M, Gautschi M, Nuoffer JM. Reversal of cardiomyopathy in propionic acidemia after liver transplantation: a 10-year follow-up. Transpl Int. 2015;28(12):1447\u201350.","journal-title":"Transpl Int"},{"issue":"3","key":"2233_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4097\/kjae.2013.65.3.257","volume":"65","author":"J Ryu","year":"2013","unstructured":"Ryu J, Shin YH, Ko JS, Gwak MS, Kim GS. Intractable metabolic acidosis in a child with propionic acidemia undergoing liver transplantation\u2014a case report. Korean J Anesthesiol. 2013;65(3):257\u201361.","journal-title":"Korean J Anesthesiol"},{"issue":"3","key":"2233_CR29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1399-3046.2011.01607.x","volume":"16","author":"M Kasahara","year":"2012","unstructured":"Kasahara M, Sakamoto S, Kanazawa H, Karaki C, Kakiuchi T, Shigeta T, et al. Living-donor liver transplantation for propionic acidemia. Pediatr Transplant. 2012;16(3):230\u20134.","journal-title":"Pediatr Transplant"},{"issue":"5","key":"2233_CR30","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jpeds.2010.12.031","volume":"158","author":"K Ameloot","year":"2011","unstructured":"Ameloot K, Vlasselaers D, Dupont M, Meersseman W, Desmet L, Vanhaecke J, et al. Left ventricular assist device as bridge to liver transplantation in a patient with propionic acidemia and cardiogenic shock. J Pediatr. 2011;158(5):866\u20137.","journal-title":"J Pediatr"},{"issue":"1","key":"2233_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jpeds.2009.07.002","volume":"156","author":"S Romano","year":"2010","unstructured":"Romano S, Valayannopoulos V, Touati G, Jais JP, Rabier D, de Keyzer Y, et al. Cardiomyopathies in propionic aciduria are reversible after liver transplantation. J Pediatr. 2010;156(1):128\u201334.","journal-title":"J Pediatr"},{"issue":"5","key":"2233_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1399-3046.2006.00536.x","volume":"10","author":"D Manzoni","year":"2006","unstructured":"Manzoni D, Spotti A, Carrara B, Gritti P, Sonzogni V. Anaesthesia for liver transplantation in two infants with an organic acidaemia. Pediatr Transplant. 2006;10(5):623\u20138.","journal-title":"Pediatr Transplant"},{"issue":"2","key":"2233_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1023\/B:BOLI.0000028778.54210.13","volume":"27","author":"T Yorifuji","year":"2004","unstructured":"Yorifuji T, Kawai M, Mamada M, Kurokawa K, Egawa H, Shigematsu Y, et al. Living-donor liver transplantation for propionic acidaemia. J Inherit Metab Dis. 2004;27(2):205\u201310.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"2233_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1034\/j.1399-3046.2002.02009.x","volume":"6","author":"LK Kayler","year":"2002","unstructured":"Kayler LK, Merion RM, Lee S, Sung RS, Punch JD, Rudich SM, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant. 2002;6(4):295\u2013300.","journal-title":"Pediatr Transplant"},{"issue":"2","key":"2233_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/archdischild-2015-310023","volume":"103","author":"R Kohli","year":"2018","unstructured":"Kohli R, Cortes M, Heaton ND, Dhawan A. Liver transplantation in children: state of the art and future perspectives. Arch Dis Child. 2018;103(2):192\u20138.","journal-title":"Arch Dis Child"},{"key":"2233_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","volume":"9","author":"MR Baumgartner","year":"2014","unstructured":"Baumgartner MR, H\u00f6rster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2233_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ymgme.2020.02.004","volume":"130","author":"A Kovacevic","year":"2020","unstructured":"Kovacevic A, Garbade SF, Hoffmann GF, Gorenflo M, Kolker S, Staufner C. Cardiac phenotype in propionic academia\u2014results of an observational monocentric study. Mol Genet Metab. 2020;130(1):41\u20138.","journal-title":"Mol Genet Metab"},{"issue":"12","key":"2233_CR38","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/jhg.2013.97","volume":"58","author":"D Fujisawa","year":"2013","unstructured":"Fujisawa D, Nakamura K, Mitsubuchi H, Ohura T, Shigematsu Y, Yorifuji T, et al. Clinical features and management of organic acidemias in Japan. J Hum Genet. 2013;58(12):769\u201374.","journal-title":"J Hum Genet"},{"issue":"4","key":"2233_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/MOP.0000000000000235","volume":"27","author":"JC Lui","year":"2015","unstructured":"Lui JC, Garrison P, Baron J. Regulation of body growth. Curr Opin Pediatr. 2015;27(4):502\u201310.","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"2233_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ymgme.2019.02.003","volume":"126","author":"F Molema","year":"2019","unstructured":"Molema F, Gleich F, Burgard P, van der Ploeg AT, Summar ML, Chapman KA, et al. Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: options for treatment. Mol Genet Metab. 2019;126(4):397\u2013405.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"2233_CR41","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/01.tp.0000167995.46778.72","volume":"80","author":"D Morioka","year":"2005","unstructured":"Morioka D, Takada Y, Kasahara M, Ito T, Uryuhara K, Ogawa K, et al. Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors. Transplantation. 2005;80(5):623\u20138.","journal-title":"Transplantation"},{"issue":"5","key":"2233_CR42","doi-asserted-by":"publisher","first-page":"470","DOI":"10.21037\/hbsn.2019.03.04","volume":"8","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG, et al. Perioperative characteristics and management of liver transplantation for isolated methylmalonic acidemia-the largest experience in China. Hepatobiliary Surg Nutr. 2019;8(5):470\u20139.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"2233_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1399-3046.2012.01649.x","volume":"16","author":"KA Chapman","year":"2012","unstructured":"Chapman KA, Summar ML, Enns GM. Propionic acidemia: to liver transplant or not to liver transplant? Pediatr Transplant. 2012;16(3):209\u201310.","journal-title":"Pediatr Transplant"},{"issue":"4","key":"2233_CR44","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1111\/ajt.16400","volume":"21","author":"S Sivananthan","year":"2021","unstructured":"Sivananthan S, Had\u017ei\u0107 N, Dhawan A, Heaton ND, Vara R. Fatal metabolic stroke in a child with propionic acidemia 11 years post liver transplant. Am J Transplant. 2021;21(4):1637\u201340.","journal-title":"Am J Transplant"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02233-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02233-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02233-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T11:17:10Z","timestamp":1666523830000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02233-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2233"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02233-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"5 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants, and our study was approved by the Ethical Committee of Beijing Friendship Hospital, Capital Medical University (No. 2020-P2-094-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflict of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}